Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2010 - 2026)

Jazz Pharmaceuticals' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$51.9 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 25.36% year-over-year to -$51.9 million; the TTM figure through Mar 2026 stood at -$39.5 million (down 156.12% YoY), while the FY2025 annual figure was -$29.0 million, down 231.15% from the prior year.
• Other Working Capital Changes was -$51.9 million for Q1 2026 at Jazz Pharmaceuticals, down from -$27.5 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $89.8 million in Q4 2023 to a low of -$51.9 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged $1.9 million across 5 years, with a median of $1.6 million in 2023.
• Biggest YoY gain for Other Working Capital Changes was 2219.75% in 2025; the steepest drop was 980.66% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$42.6 million in 2022, then soared by 310.99% to $89.8 million in 2023, then tumbled by 75.7% to $21.8 million in 2024, then plunged by 226.02% to -$27.5 million in 2025, then slumped by 88.78% to -$51.9 million in 2026.
• The last three Other Working Capital Changes figures came in at -$51.9 million (Q1 2026), -$27.5 million (Q4 2025), and -$6.3 million (Q3 2025), per Business Quant data.